Clinical Trials Sponsored by Richmond Pharmacology Limited

Total 27 results

Richmond Pharmacology Limited

Completed

Food and Insulin Effect on QT/QTC Interval of ECG (C11035)

Effects of Different Meals on the QT/QTc Interval | Insulin and Oral Hypoglycemic [Antidiabetic] Drugs Causing Adverse Effects in Therapeutic Use | C-Peptide Effects on the QT/QTc Interval | Moxifloxacin ECG Profile in Fed and Fasted State | Japanese vs. Caucasian TQT Comparison

United Kingdom
Inotrem
Richmond Pharmacology Limited

Completed

Safety, Tolerability and Pharmacokinetic Profiles of MOTREM (LR12) in Healthy Male Subjects

Healthy Subjects

United Kingdom
Richmond Research Institute
Richmond Pharmacology Limited

Recruiting

Development of a Non-invasive Screening Tool to Predict NAFLD

Healthy

United Kingdom
Richmond Research Institute
Richmond Pharmacology Limited

Completed

Effect of Glucose on QTc Interval in Type 1 Diabetes

Diabetes

United Kingdom
Richmond Research Institute
Richmond Pharmacology Limited

Recruiting

Serological and PCR Testing for COVID-19

COVID-19

United Kingdom
Takeda
Richmond Pharmacology Limited

Completed

Safety, Tolerability, and Pharmacokinetics of TAK-438 in Healthy Western Male Subjects, Preliminary Food Effect Analysis, and an Ethnic Comparison With Japanese Subjects

Dose Finding Study
SPD Development Company Limited
Richmond Pharmacology Limited

Completed

Urine Sample Collection From Non Pregnant Peri and Post-menopausal Women

Pregnancy
Pacira Pharmaceuticals, Inc
Richmond Pharmacology Limited

Completed

Phase 1 Thorough QT Study in Young Healthy Volunteers (TQT)

Postoperative Pain

United Kingdom
Aegerion Pharmaceuticals, Inc.
Richmond Pharmacology Limited

Completed

Phase I Study of the Safety, Tolerability, PK & PD of Lomitapide in Japanese and Caucasian Subjects With Elevated LDL-C

Healthy Volunteer

United Kingdom
Forendo Pharma Ltd
Richmond Pharmacology Limited

Completed

A Relative Bioavailability Study of FOR-6219 in Capsule and Tablet Formulations

Relative Bioavailability

United Kingdom
Forendo Pharma Ltd
Richmond Pharmacology Limited

Completed

A Study to Investigate the Safety, Tolerability, Food Effect, Pharmacokinetics and Pharmacodynamics of FOR-6219

Endometriosis

United Kingdom
Swedish Orphan Biovitrum
Richmond Pharmacology Limited

Terminated

Safety and Tolerability of SOBI002 in Healthy Volunteers Following Single and Repeated Administration

Healthy

United Kingdom
Helperby Therapeutics Ltd
Richmond Pharmacology Limited

Completed

Effect of Minocycline & Amoxicillin on Antibiotic Resistant Bacteria and Indigenous Microbiotas (ANTIRESDEV)

Antibiotic Resistant Bacteria

United Kingdom
Futura Medical Developments Ltd.
Richmond Pharmacology Limited

Completed

Study to Determine the Effect of a Newly Formulated Tetracaine Product PET500 on Penile Skin Sensation (FM48)

Healthy Volunteers
Medicines for Malaria Venture
Richmond Pharmacology Limited

Completed

Healthy Volunteer Study of the Pharmacokinetics of Oral Piperaquine With OZ439 + TPGS Formulation in the Fasted State

Malaria

United Kingdom
Medicines for Malaria Venture
Richmond Pharmacology Limited

Completed

Open Label Pharmacokinetic Study of OZ439 and Piperaquine on Administration of OZ439+TPGS Granules for Oral Suspension Alone or With Either Piperaquine Phosphate Tablets or Granules for Oral Solution in Healthy Volunteers

Malaria

United Kingdom
Medicines for Malaria Venture
Richmond Pharmacology Limited

Completed

Atoguanil BA Study

Bioavailability

United Kingdom
Medicines for Malaria Venture
Richmond Pharmacology Limited

Completed

Determine the Tolerability and Safety of Atovaquone-proguanil (ATV-PG) Co-administered With Amodiaquine (AQ)

Malaria

United Kingdom
Futura Medical Developments Ltd.
Richmond Pharmacology Limited

Completed

Clinical Trial of Topically-applied Glyceryl Trinitrate (GTN) for the Treatment of Erectile Dysfunction (ED)

Erectile Dysfunction

United Kingdom
Medicines for Malaria Venture
Richmond Pharmacology Limited

Completed

A Study to Evaluate the Pharmacokinetics of Oral Formulations of MMV390048 Administered Fasted to Healthy Volunteers

Malaria

United Kingdom
Medicines for Malaria Venture
Richmond Pharmacology Limited

Completed

A FIH Study to Investigate the Safety, Tolerability and PK of P218

Malaria

United Kingdom
Dr Jorg Taubel
Richmond Pharmacology Limited; National Amyloidosis Centre

Not yet recruiting

PATHWAY-RCT: Preventing Admission To Hospital With Attr cardiomyopathY (PATHWAY-RCT)

Cardiac Amyloidosis

United Kingdom
Medicines for Malaria Venture
Richmond Pharmacology Limited; PharmaKinetic Ltd

Active, not recruiting

A Healthy Volunteer Safety Study of Pyronaridine Tetraphosphate Taken in Combination With Piperaquine Tetraphosphate

Healthy

United Kingdom
Evotec Neurosciences GmbH
Richmond Pharmacology Limited

Completed

The Effects of a Novel NMDA NR2B-Subtype Selective Antagonist, EVT 101, on Brain Function

Human Volunteers

United Kingdom
St George's, University of London
Novartis Vaccines; European Union; Richmond Pharmacology Limited

Terminated

Safety Study Of Nasal HIV Vaccine Adjuvanted With LTK63

HIV Infections

United Kingdom
UCB Biopharma S.P.R.L.
Pharmaceutical Research Associates; Richmond Pharmacology Limited; Eurofins; ACM... and other collaborators

Completed

Study to Compare Properties of Epratuzumab When Given as an Injection Under the Skin or Directly Into the Blood

Systemic Lupus Erythematosus

United Kingdom
Laboratorios Richmond S.A.C.I.F.
FP Clinical Pharma S.R.L.; Syngene International Limited

Completed

A Phase I Study Comparing Pharmacokinetics and Safety of Bevacizumab

Pharmacokinetics | Safety Issues

Argentina

Clinical Trials Sponsored by Richmond Pharmacology Limited

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Equatorial Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations